As CXCL8 is a key molecule required for the recruitment of neutrophils and their successful extravasation from the blood vessel system [46], this disrupted response to CXCL8 might explain, why the patient remained susceptible to bacterial and fungal infections throughout therapy. The gene discussed is CXCL8; the disease is fungal infectious disease.